Paxlovid is no longer free for everyone, but many people can still get it at no cost depending on their insurance status. The U.S. government stopped broadly distributing free Paxlovid on November 1, 2023, when the drug moved to the commercial market. Without insurance or assistance programs, a five-day course now carries a list price of about $1,390 to $1,500.
What Changed in November 2023
During the pandemic, the federal government purchased Paxlovid directly from Pfizer and distributed it for free through pharmacies nationwide. That program ended on November 1, 2023, when Paxlovid (along with Merck’s molnupiravir) officially transitioned to the commercial market. Since then, the drug has been sold through the same channels as any other prescription medication, meaning insurance coverage, copays, and out-of-pocket costs all apply.
Pfizer’s wholesale list price for a single course of Paxlovid is $1,496.13 as of October 2025. That’s the sticker price before any insurance discounts, rebates, or assistance programs. What you actually pay depends entirely on your coverage.
Who Can Still Get Paxlovid for Free
A federal patient assistance program, operated by Pfizer on behalf of the U.S. Department of Health and Human Services, continues to provide Paxlovid at no cost to eligible patients through December 31, 2026. You may qualify if you fall into one of these categories:
- Medicare beneficiaries who face high copays or lack prescription drug coverage
- Medicaid enrollees
- TRICARE and VA Community Care Network patients
- Uninsured individuals
This program, known as the USG Patient Assistance Program (USG PAP), has its own eligibility requirements. It’s not automatic. You or your pharmacist need to enroll you before you can receive the drug at no cost. The December 2026 end date is the current cutoff, though it has been extended before.
What If You Have Private Insurance
If you have commercial (employer-sponsored or marketplace) insurance, Paxlovid is covered like any other brand-name prescription. Your cost depends on your plan’s formulary, your deductible, and your copay tier. Some people pay $0 or a modest copay, while others on high-deductible plans could face hundreds of dollars out of pocket.
Pfizer runs a separate copay savings program called PAXCESS for commercially insured patients. This can reduce or eliminate your copay. It’s distinct from the government assistance program, which is reserved for government-insured and uninsured patients. You can check eligibility or enroll through the PAXCESS patient portal online, by texting PAXCESS to 87161, or by calling 1-877-219-7225.
How Medicare Covers Paxlovid
Medicare Part D plans cover Paxlovid as a standard prescription benefit. Currently, Medicare patients can access Paxlovid either through their Part D plan (with a rebate program that offsets costs) or by enrolling directly in the USG PAP for no-cost access. If your Part D copay is high and you can’t afford the treatment, the USG PAP is specifically designed to fill that gap.
Starting in 2025, Medicare’s $2,000 annual out-of-pocket cap on prescription drugs also helps limit what beneficiaries pay across all their medications, which may reduce Paxlovid costs for some enrollees even without the assistance program.
How to Get Help at the Pharmacy
If you’ve been prescribed Paxlovid and are worried about cost, the most practical step is to contact Pfizer’s support line before or immediately after getting your prescription. COVID-19 antivirals work best when started within five days of symptom onset, so speed matters. Here’s what to do:
Visit PAXCESSPatientPortal.com to check which program fits your situation. If you’re uninsured or on Medicare, Medicaid, TRICARE, or VA coverage, you’ll be directed toward the USG PAP. If you’re commercially insured, you’ll be pointed to the copay savings program. You can also call 1-877-219-7225 (Monday through Friday, 9 a.m. to 9 p.m. ET, or weekends 9 a.m. to 5 p.m. ET) and a representative will walk you through enrollment. Your pharmacist can also help initiate enrollment at the point of sale in many cases.
The key thing to know: don’t skip filling the prescription because of sticker shock. Between insurance coverage and assistance programs, most people in the U.S. can still access Paxlovid for significantly less than the list price, and many pay nothing at all.